SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

20 Jan 2023 Evaluate
The Total revenue for the quarter ended December 2022 of  Rs. 346.18 millions grew by 217.71% from Rs. 108.96 millions.The Total Profit for the quarter ended December 2022 of Rs. 20.75 millions grew from Rs.-9.93 millions Operating profit Margin for the quarter ended December 2022 improved to 28.45% as compared to -3.26% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 346.18 108.96 217.71 734.67 431.15 70.40 656.33 744.15 -11.80
Other Income 0.05 0.41 -87.80 1.90 0.63 201.59 1.26 2.56 -50.78
PBIDT 28.45 -3.26 -972.70 63.18 -22.44 -381.55 6.93 -49.04 -114.13
Interest 0.56 0.33 69.70 0.84 0.63 33.33 2.84 0.55 416.36
PBDT 27.89 -3.59 -876.88 62.34 -23.07 -370.22 4.09 -49.59 -108.25
Depreciation 7.14 6.34 12.62 21.10 18.88 11.76 25.81 23.55 9.60
PBT 20.75 -9.93 -308.96 41.24 -41.95 -198.31 -21.72 -73.14 -70.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.66 -17.49 -73.36
PAT 20.75 -9.93 -308.96 41.24 -41.95 -198.31 -17.06 -55.65 -69.34
Equity 318.90 232.90 36.93 318.90 232.90 36.93 232.90 215.40 8.12
PBIDTM(%) 8.22 -2.99 -374.68 8.60 -5.20 -265.23 1.06 -6.59 -116.02

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×